Increased sensitivity to mitomycin C-induced sister chromatid exchange in lymphocytes from patients undergoing hyperbaric oxygen therapy | Canada Hyperbarics Skip to main content
Study Environ Mol Mutagen 2006

Increased sensitivity to mitomycin C-induced sister chromatid exchange in lymphocytes from patients undergoing hyperbaric oxygen therapy

Duydu Y, Ustündağ A, Aydin A, Eken A, Dündar K, Uzun G — Environ Mol Mutagen, 2006

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

Researchers examined how hyperbaric oxygen therapy (HBOT) affects DNA damage markers in the blood cells of patients undergoing treatment for diabetic foot ulcers.

What They Found

They observed a statistically significant increase in mean sister chromatid exchange (SCE) per cell (P < 0.05; n = 11) immediately after the first HBOT session. While SCE frequency gradually decreased after the 5th and 10th sessions, returning to baseline, lymphocytes retained a significantly higher sensitivity (P < 0.05; n = 4) to mitomycin C-induced SCE even one day after the last of 10 daily HBOT treatments.

Canadian Relevance

This study covers diabetic foot ulcers, which is a Health Canada-recognized indication for hyperbaric oxygen therapy.

Study Limitations

A key limitation was the decreasing number of patients available for sampling throughout the 10-session therapy protocol.

Was this summary helpful?

Study Details

Study Type Study
Category Uncategorised
Source Pubmed
PubMed ID 16355392
Year Published 2006
Journal Environ Mol Mutagen
MeSH Terms Adult; Aged; Antioxidants; Chromosome Aberrations; Chromosomes, Human; DNA Damage; Female; Humans; Hyperbaric Oxygenation; Lymphocytes; Male; Middle Aged; Mitomycin; Mitomycins; Sensitivity and Specificity; Sister Chromatid Exchange; T-Lymphocytes; Time Factors

Cite This Study

Share

Find a Canadian Clinic Treating Uncategorised

Browse verified hyperbaric facilities across Canada.

View Canadian Facilities

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.